Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...
The Central Drug Standards Control Organization (CDSCO) has granted a license to Biolumpivaxin, India’s first vaccine against ...
In the last two years, around 200,000 cattle have died, millions lost their milk production capabilities due to LSD ...
Our Bureau, Bengaluru Monday, February 10, 2025, 13:45 Hrs [IST] ...
Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and ...
Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...
Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.
Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...
The vaccine Biolumpivaxin, developed jointly by the Indian Council of Agricultural Research (ICAR) and Biovet, will enable ...
Biovet, a part of Bharat Biotech, on Monday said it has received approval from the Central Drug Standards Control ...
The Central Drug Standards Control Organization (CDSCO) has granted approval to Biolumpivaxin, India's first vaccine against ...
Biovet, a part of Bharat Biotech, has received approval to market Biolumpvaxin, a groundbreaking DIVA marker vaccine for lumpy skin disease in cattle and buffaloes. The launch of this vaccine marks a ...